These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36889654)

  • 41. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
    Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
    Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
    Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorine-18-Labeled Diaryl-azines as Improved β-Amyloid Imaging Tracers: From Bench to First-in-Human Studies.
    Li Y; Zhou K; Zhang X; Zhao H; Wang X; Dong R; Wang Y; Chen B; Yan XX; Dai J; Sui Y; Zhang J; Cui M
    J Med Chem; 2023 Apr; 66(7):4603-4616. PubMed ID: 36932961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
    Higuchi M
    Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques.
    Yousefi BH; Drzezga A; von Reutern B; Manook A; Schwaiger M; Wester HJ; Henriksen G
    ACS Med Chem Lett; 2011 Sep; 2(9):673-7. PubMed ID: 24900362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary PET Study of
    Oh SJ; Kim MH; Han SJ; Kang KJ; Ko IO; Kim Y; Park JA; Choi JY; Lee KC; Chi DY; Lee YJ; Kim KM
    Mol Pharm; 2017 Sep; 14(9):3114-3120. PubMed ID: 28737945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
    Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
    J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography.
    Henriksen G; Yousefi BH; Drzezga A; Wester HJ
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S75-81. PubMed ID: 18224319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography.
    Furumoto S; Okamura N; Furukawa K; Tashiro M; Ishikawa Y; Sugi K; Tomita N; Waragai M; Harada R; Tago T; Iwata R; Yanai K; Arai H; Kudo Y
    Mol Imaging Biol; 2013 Aug; 15(4):497-506. PubMed ID: 23362000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
    Lee I; Yang J; Lee JH; Choe YS
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's disease.
    Ono M; Watanabe R; Kawashima H; Cheng Y; Kimura H; Watanabe H; Haratake M; Saji H; Nakayama M
    J Med Chem; 2009 Oct; 52(20):6394-401. PubMed ID: 19757822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease.
    Sundaram GS; Dhavale D; Prior JL; Sivapackiam J; Laforest R; Kotzbauer P; Sharma V
    EJNMMI Res; 2015 Dec; 5(1):112. PubMed ID: 26061601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal evaluation of a novel BChE PET tracer as an early
    Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
    Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.